MYGN
Myriad Genetics Inc
NASDAQ · Biotechnology
$5.12
+0.02 (+0.39%)
Open$5.12
Previous Close$5.10
Day High$5.28
Day Low$5.01
52W High$15.47
52W Low$3.76
Volume—
Avg Volume863.3K
Market Cap477.25M
P/E Ratio—
EPS$-4.34
SectorBiotechnology
Analyst Ratings
Sell
18 analysts
Price Target
+709.4% upside
Current
$5.12
$5.12
Target
$41.44
$41.44
$29.39
$41.44 avg
$63.29
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 861.76M | 808.10M | 75.18M |
| Net Income | -130,974,596 | -110,537,449 | -15,172,295 |
| Profit Margin | -15.2% | -14.4% | -20.2% |
| EBITDA | -62,965,867 | -56,092,998 | -16,149,167 |
| Free Cash Flow | — | — | -9,917,338 |
| Rev Growth | +6.6% | +6.6% | -4.8% |
| Debt/Equity | 0.06 | 0.06 | 0.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |